aluates Reports

$ 0.0

Automative

Global PD-L1 Biomarker Testing Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-6F9402

Global PD L1 Biomarker Testing Market Size Status and Forecast 2022

BUY CHAPTERS

Global PD-L1 Biomarker Testing Market Research Report 2024

Code: QYRE-Auto-6F9402

Report

January 2024

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Agilent Technologies

Roche

Merck

Bristol–Myers Squibb

Astrazeneca plc

Ono Pharmaceutical

Regeneron

Innovent

Hengrui Medicine

Junshi Biosciences

PD-L1 Biomarker Testing Market Size

The global PD-L1 Biomarker Testing market was valued at US$ 1470.5 million in 2023 and is anticipated to reach US$ 14870 million by 2030, witnessing a CAGR of 38.7% during the forecast period 2024-2030.

PD-L1 Biomarker Testing Market

PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to "trick" the immune system, and avoid being attacked as foreign, harmful substances.

Current PD-L1 testing is based on immunohistochemistry (IHC) methods. Immunohistochemistry (IHC) is the process whereby antibodies are used to detect proteins (antigens) in cells within a tissue section (for instance liver, pancreas or the heart).

PD-L1 is a ligand that binds to PD-1 (programmed cell death-1), expressed on activated T cells, to evade anti-tumor responses. PD-L1 plays a role in inhibiting T cell activation and proliferation and has emerged as an important target in cancer treatment. PD-L1 protein detection by immunohistochemistry (IHC) testing is widely used as a predictive biomarker assay for anti–PD-1/PD-L1 therapies.

PDL1 testing is used to find out if you have a cancer that may benefit from immunotherapy.

The classification of PD-L1 Biomarker Testing includes PD-L1 (22C3), PD-L1 (28-8), PD-L1 (SP142), PD-L1 (SP263) and Other, and the revenue proportion of PD-L1 (22C3) in 2019 is about 21.68%.

PD-L1 Biomarker Testing is widely used in Hospital and Diagnostic Laboratories. The most proportion of PD-L1 Biomarker Testing is Hospital, and the proportion in 2019 is about 52.7%.

North Americas is the largest consumption place, with a consumption market share nearly 55.63% in 2019. Following North Americas, Europe is the second largest consumption place with the consumption market share of 26.7%.

This report aims to provide a comprehensive presentation of the global market for PD-L1 Biomarker Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PD-L1 Biomarker Testing.

Report Scope

The PD-L1 Biomarker Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PD-L1 Biomarker Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the PD-L1 Biomarker Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of PD-L1 Biomarker Testing Market Report

Report Metric	Details
Report Name	PD-L1 Biomarker Testing Market
Accounted market size in 2023	US$ 1470.5 million
Forecasted market size in 2030	US$ 14870 million
CAGR	38.7%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	PD-L1 (22C3) PD-L1(28-8) PD-L1 (SP142) PD-L1 (SP263) Other
Segment by Application	Hospital Diagnostic Center Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Agilent Technologies, Roche, Merck, Bristol-Myers Squibb, AstraZeneca, Ono Pharmaceutical, Regeneron, Innovent, Hengrui Medicine, Junshi Biosciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of PD-L1 Biomarker Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is PD-L1 Biomarker Testing Market growing?

Ans: The PD-L1 Biomarker Testing Market witnessing a CAGR of 38.7% during the forecast period 2024-2030.

What is the PD-L1 Biomarker Testing Market size in 2030?

Ans: The PD-L1 Biomarker Testing Market size in 2030 will be US$ 14870 million.

What is the PD-L1 Biomarker Testing Market share by application?

Ans: The most proportion of PD-L1 Biomarker Testing is Hospital, and the proportion in 2019 is about 52.7%.

What is the PD-L1 Biomarker Testing Market share by region?

Ans: North Americas is the largest consumption place, with a consumption market share nearly 55.63% in 2019.

Who are the main players in the PD-L1 Biomarker Testing Market report?

Ans: The main players in the PD-L1 Biomarker Testing Market are Agilent Technologies, Roche, Merck, Bristol-Myers Squibb, AstraZeneca, Ono Pharmaceutical, Regeneron, Innovent, Hengrui Medicine, Junshi Biosciences

What are the Application segmentation covered in the PD-L1 Biomarker Testing Market report?

Ans: The Applications covered in the PD-L1 Biomarker Testing Market report are Hospital, Diagnostic Center, Others

What are the Type segmentation covered in the PD-L1 Biomarker Testing Market report?

Ans: The Types covered in the PD-L1 Biomarker Testing Market report are PD-L1 (22C3), PD-L1(28-8), PD-L1 (SP142), PD-L1 (SP263), Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global PD-L1 Biomarker Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 PD-L1 (22C3)

1.2.3 PD-L1(28-8)

1.2.4 PD-L1 (SP142)

1.2.5 PD-L1 (SP263)

1.2.6 Other

1.3 Market by Application

1.3.1 Global PD-L1 Biomarker Testing Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Diagnostic Center

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global PD-L1 Biomarker Testing Market Perspective (2019-2030)

2.2 PD-L1 Biomarker Testing Growth Trends by Region

2.2.1 Global PD-L1 Biomarker Testing Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 PD-L1 Biomarker Testing Historic Market Size by Region (2019-2024)

2.2.3 PD-L1 Biomarker Testing Forecasted Market Size by Region (2025-2030)

2.3 PD-L1 Biomarker Testing Market Dynamics

2.3.1 PD-L1 Biomarker Testing Industry Trends

2.3.2 PD-L1 Biomarker Testing Market Drivers

2.3.3 PD-L1 Biomarker Testing Market Challenges

2.3.4 PD-L1 Biomarker Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top PD-L1 Biomarker Testing Players by Revenue

3.1.1 Global Top PD-L1 Biomarker Testing Players by Revenue (2019-2024)

3.1.2 Global PD-L1 Biomarker Testing Revenue Market Share by Players (2019-2024)

3.2 Global PD-L1 Biomarker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by PD-L1 Biomarker Testing Revenue

3.4 Global PD-L1 Biomarker Testing Market Concentration Ratio

3.4.1 Global PD-L1 Biomarker Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by PD-L1 Biomarker Testing Revenue in 2023

3.5 PD-L1 Biomarker Testing Key Players Head office and Area Served

3.6 Key Players PD-L1 Biomarker Testing Product Solution and Service

3.7 Date of Enter into PD-L1 Biomarker Testing Market

3.8 Mergers & Acquisitions, Expansion Plans

4 PD-L1 Biomarker Testing Breakdown Data by Type

4.1 Global PD-L1 Biomarker Testing Historic Market Size by Type (2019-2024)

4.2 Global PD-L1 Biomarker Testing Forecasted Market Size by Type (2025-2030)

5 PD-L1 Biomarker Testing Breakdown Data by Application

5.1 Global PD-L1 Biomarker Testing Historic Market Size by Application (2019-2024)

5.2 Global PD-L1 Biomarker Testing Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America PD-L1 Biomarker Testing Market Size (2019-2030)

6.2 North America PD-L1 Biomarker Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America PD-L1 Biomarker Testing Market Size by Country (2019-2024)

6.4 North America PD-L1 Biomarker Testing Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe PD-L1 Biomarker Testing Market Size (2019-2030)

7.2 Europe PD-L1 Biomarker Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe PD-L1 Biomarker Testing Market Size by Country (2019-2024)

7.4 Europe PD-L1 Biomarker Testing Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific PD-L1 Biomarker Testing Market Size (2019-2030)

8.2 Asia-Pacific PD-L1 Biomarker Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific PD-L1 Biomarker Testing Market Size by Region (2019-2024)

8.4 Asia-Pacific PD-L1 Biomarker Testing Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America PD-L1 Biomarker Testing Market Size (2019-2030)

9.2 Latin America PD-L1 Biomarker Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America PD-L1 Biomarker Testing Market Size by Country (2019-2024)

9.4 Latin America PD-L1 Biomarker Testing Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa PD-L1 Biomarker Testing Market Size (2019-2030)

10.2 Middle East & Africa PD-L1 Biomarker Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa PD-L1 Biomarker Testing Market Size by Country (2019-2024)

10.4 Middle East & Africa PD-L1 Biomarker Testing Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Agilent Technologies

11.1.1 Agilent Technologies Company Detail

11.1.2 Agilent Technologies Business Overview

11.1.3 Agilent Technologies PD-L1 Biomarker Testing Introduction

11.1.4 Agilent Technologies Revenue in PD-L1 Biomarker Testing Business (2019-2024)

11.1.5 Agilent Technologies Recent Development

11.2 Roche

11.2.1 Roche Company Detail

11.2.2 Roche Business Overview

11.2.3 Roche PD-L1 Biomarker Testing Introduction

11.2.4 Roche Revenue in PD-L1 Biomarker Testing Business (2019-2024)

11.2.5 Roche Recent Development

11.3 Merck

11.3.1 Merck Company Detail

11.3.2 Merck Business Overview

11.3.3 Merck PD-L1 Biomarker Testing Introduction

11.3.4 Merck Revenue in PD-L1 Biomarker Testing Business (2019-2024)

11.3.5 Merck Recent Development

11.4 Bristol-Myers Squibb

11.4.1 Bristol-Myers Squibb Company Detail

11.4.2 Bristol-Myers Squibb Business Overview

11.4.3 Bristol-Myers Squibb PD-L1 Biomarker Testing Introduction

11.4.4 Bristol-Myers Squibb Revenue in PD-L1 Biomarker Testing Business (2019-2024)

11.4.5 Bristol-Myers Squibb Recent Development

11.5 AstraZeneca

11.5.1 AstraZeneca Company Detail

11.5.2 AstraZeneca Business Overview

11.5.3 AstraZeneca PD-L1 Biomarker Testing Introduction

11.5.4 AstraZeneca Revenue in PD-L1 Biomarker Testing Business (2019-2024)

11.5.5 AstraZeneca Recent Development

11.6 Ono Pharmaceutical

11.6.1 Ono Pharmaceutical Company Detail

11.6.2 Ono Pharmaceutical Business Overview

11.6.3 Ono Pharmaceutical PD-L1 Biomarker Testing Introduction

11.6.4 Ono Pharmaceutical Revenue in PD-L1 Biomarker Testing Business (2019-2024)

11.6.5 Ono Pharmaceutical Recent Development

11.7 Regeneron

11.7.1 Regeneron Company Detail

11.7.2 Regeneron Business Overview

11.7.3 Regeneron PD-L1 Biomarker Testing Introduction

11.7.4 Regeneron Revenue in PD-L1 Biomarker Testing Business (2019-2024)

11.7.5 Regeneron Recent Development

11.8 Innovent

11.8.1 Innovent Company Detail

11.8.2 Innovent Business Overview

11.8.3 Innovent PD-L1 Biomarker Testing Introduction

11.8.4 Innovent Revenue in PD-L1 Biomarker Testing Business (2019-2024)

11.8.5 Innovent Recent Development

11.9 Hengrui Medicine

11.9.1 Hengrui Medicine Company Detail

11.9.2 Hengrui Medicine Business Overview

11.9.3 Hengrui Medicine PD-L1 Biomarker Testing Introduction

11.9.4 Hengrui Medicine Revenue in PD-L1 Biomarker Testing Business (2019-2024)

11.9.5 Hengrui Medicine Recent Development

11.10 Junshi Biosciences

11.10.1 Junshi Biosciences Company Detail

11.10.2 Junshi Biosciences Business Overview

11.10.3 Junshi Biosciences PD-L1 Biomarker Testing Introduction

11.10.4 Junshi Biosciences Revenue in PD-L1 Biomarker Testing Business (2019-2024)

11.10.5 Junshi Biosciences Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Agilent Technologies

Roche

Merck

Bristol–Myers Squibb

Astrazeneca plc

Ono Pharmaceutical

Regeneron

Innovent

Hengrui Medicine

Junshi Biosciences

List of Tables

Table 1. Global PD-L1 Biomarker Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of PD-L1 (22C3)

Table 3. Key Players of PD-L1(28-8)

Table 4. Key Players of PD-L1 (SP142)

Table 5. Key Players of PD-L1 (SP263)

Table 6. Key Players of Other

Table 7. Global PD-L1 Biomarker Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global PD-L1 Biomarker Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global PD-L1 Biomarker Testing Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global PD-L1 Biomarker Testing Market Share by Region (2019-2024)

Table 11. Global PD-L1 Biomarker Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global PD-L1 Biomarker Testing Market Share by Region (2025-2030)

Table 13. PD-L1 Biomarker Testing Market Trends

Table 14. PD-L1 Biomarker Testing Market Drivers

Table 15. PD-L1 Biomarker Testing Market Challenges

Table 16. PD-L1 Biomarker Testing Market Restraints

Table 17. Global PD-L1 Biomarker Testing Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global PD-L1 Biomarker Testing Market Share by Players (2019-2024)

Table 19. Global Top PD-L1 Biomarker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 Biomarker Testing as of 2023)

Table 20. Ranking of Global Top PD-L1 Biomarker Testing Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by PD-L1 Biomarker Testing Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players PD-L1 Biomarker Testing Product Solution and Service

Table 24. Date of Enter into PD-L1 Biomarker Testing Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global PD-L1 Biomarker Testing Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global PD-L1 Biomarker Testing Revenue Market Share by Type (2019-2024)

Table 28. Global PD-L1 Biomarker Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global PD-L1 Biomarker Testing Revenue Market Share by Type (2025-2030)

Table 30. Global PD-L1 Biomarker Testing Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global PD-L1 Biomarker Testing Revenue Market Share by Application (2019-2024)

Table 32. Global PD-L1 Biomarker Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global PD-L1 Biomarker Testing Revenue Market Share by Application (2025-2030)

Table 34. North America PD-L1 Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America PD-L1 Biomarker Testing Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America PD-L1 Biomarker Testing Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe PD-L1 Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe PD-L1 Biomarker Testing Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe PD-L1 Biomarker Testing Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific PD-L1 Biomarker Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific PD-L1 Biomarker Testing Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific PD-L1 Biomarker Testing Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America PD-L1 Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America PD-L1 Biomarker Testing Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America PD-L1 Biomarker Testing Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa PD-L1 Biomarker Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa PD-L1 Biomarker Testing Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa PD-L1 Biomarker Testing Market Size by Country (2025-2030) & (US$ Million)

Table 49. Agilent Technologies Company Detail

Table 50. Agilent Technologies Business Overview

Table 51. Agilent Technologies PD-L1 Biomarker Testing Product

Table 52. Agilent Technologies Revenue in PD-L1 Biomarker Testing Business (2019-2024) & (US$ Million)

Table 53. Agilent Technologies Recent Development

Table 54. Roche Company Detail

Table 55. Roche Business Overview

Table 56. Roche PD-L1 Biomarker Testing Product

Table 57. Roche Revenue in PD-L1 Biomarker Testing Business (2019-2024) & (US$ Million)

Table 58. Roche Recent Development

Table 59. Merck Company Detail

Table 60. Merck Business Overview

Table 61. Merck PD-L1 Biomarker Testing Product

Table 62. Merck Revenue in PD-L1 Biomarker Testing Business (2019-2024) & (US$ Million)

Table 63. Merck Recent Development

Table 64. Bristol-Myers Squibb Company Detail

Table 65. Bristol-Myers Squibb Business Overview

Table 66. Bristol-Myers Squibb PD-L1 Biomarker Testing Product

Table 67. Bristol-Myers Squibb Revenue in PD-L1 Biomarker Testing Business (2019-2024) & (US$ Million)

Table 68. Bristol-Myers Squibb Recent Development

Table 69. AstraZeneca Company Detail

Table 70. AstraZeneca Business Overview

Table 71. AstraZeneca PD-L1 Biomarker Testing Product

Table 72. AstraZeneca Revenue in PD-L1 Biomarker Testing Business (2019-2024) & (US$ Million)

Table 73. AstraZeneca Recent Development

Table 74. Ono Pharmaceutical Company Detail

Table 75. Ono Pharmaceutical Business Overview

Table 76. Ono Pharmaceutical PD-L1 Biomarker Testing Product

Table 77. Ono Pharmaceutical Revenue in PD-L1 Biomarker Testing Business (2019-2024) & (US$ Million)

Table 78. Ono Pharmaceutical Recent Development

Table 79. Regeneron Company Detail

Table 80. Regeneron Business Overview

Table 81. Regeneron PD-L1 Biomarker Testing Product

Table 82. Regeneron Revenue in PD-L1 Biomarker Testing Business (2019-2024) & (US$ Million)

Table 83. Regeneron Recent Development

Table 84. Innovent Company Detail

Table 85. Innovent Business Overview

Table 86. Innovent PD-L1 Biomarker Testing Product

Table 87. Innovent Revenue in PD-L1 Biomarker Testing Business (2019-2024) & (US$ Million)

Table 88. Innovent Recent Development

Table 89. Hengrui Medicine Company Detail

Table 90. Hengrui Medicine Business Overview

Table 91. Hengrui Medicine PD-L1 Biomarker Testing Product

Table 92. Hengrui Medicine Revenue in PD-L1 Biomarker Testing Business (2019-2024) & (US$ Million)

Table 93. Hengrui Medicine Recent Development

Table 94. Junshi Biosciences Company Detail

Table 95. Junshi Biosciences Business Overview

Table 96. Junshi Biosciences PD-L1 Biomarker Testing Product

Table 97. Junshi Biosciences Revenue in PD-L1 Biomarker Testing Business (2019-2024) & (US$ Million)

Table 98. Junshi Biosciences Recent Development

Table 99. Research Programs/Design for This Report

Table 100. Key Data Information from Secondary Sources

Table 101. Key Data Information from Primary Sources

List of Figures

Figure 1. Global PD-L1 Biomarker Testing Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global PD-L1 Biomarker Testing Market Share by Type: 2023 VS 2030

Figure 3. PD-L1 (22C3) Features

Figure 4. PD-L1(28-8) Features

Figure 5. PD-L1 (SP142) Features

Figure 6. PD-L1 (SP263) Features

Figure 7. Other Features

Figure 8. Global PD-L1 Biomarker Testing Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global PD-L1 Biomarker Testing Market Share by Application: 2023 VS 2030

Figure 10. Hospital Case Studies

Figure 11. Diagnostic Center Case Studies

Figure 12. Others Case Studies

Figure 13. PD-L1 Biomarker Testing Report Years Considered

Figure 14. Global PD-L1 Biomarker Testing Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global PD-L1 Biomarker Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global PD-L1 Biomarker Testing Market Share by Region: 2023 VS 2030

Figure 17. Global PD-L1 Biomarker Testing Market Share by Players in 2023

Figure 18. Global Top PD-L1 Biomarker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 Biomarker Testing as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by PD-L1 Biomarker Testing Revenue in 2023

Figure 20. North America PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America PD-L1 Biomarker Testing Market Share by Country (2019-2030)

Figure 22. United States PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe PD-L1 Biomarker Testing Market Share by Country (2019-2030)

Figure 26. Germany PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific PD-L1 Biomarker Testing Market Share by Region (2019-2030)

Figure 34. China PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America PD-L1 Biomarker Testing Market Share by Country (2019-2030)

Figure 42. Mexico PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa PD-L1 Biomarker Testing Market Share by Country (2019-2030)

Figure 46. Turkey PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia PD-L1 Biomarker Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Agilent Technologies Revenue Growth Rate in PD-L1 Biomarker Testing Business (2019-2024)

Figure 49. Roche Revenue Growth Rate in PD-L1 Biomarker Testing Business (2019-2024)

Figure 50. Merck Revenue Growth Rate in PD-L1 Biomarker Testing Business (2019-2024)

Figure 51. Bristol-Myers Squibb Revenue Growth Rate in PD-L1 Biomarker Testing Business (2019-2024)

Figure 52. AstraZeneca Revenue Growth Rate in PD-L1 Biomarker Testing Business (2019-2024)

Figure 53. Ono Pharmaceutical Revenue Growth Rate in PD-L1 Biomarker Testing Business (2019-2024)

Figure 54. Regeneron Revenue Growth Rate in PD-L1 Biomarker Testing Business (2019-2024)

Figure 55. Innovent Revenue Growth Rate in PD-L1 Biomarker Testing Business (2019-2024)

Figure 56. Hengrui Medicine Revenue Growth Rate in PD-L1 Biomarker Testing Business (2019-2024)

Figure 57. Junshi Biosciences Revenue Growth Rate in PD-L1 Biomarker Testing Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions